ALACHUA, Fla., March 07, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced its shareholders have voted to approve completion of the company’s previously announced acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. The final voting results have been disclosed on a Form 8-K filed with the Securities and Exchange Commission. RTI Surgical anticipates closing the acquisition on Friday, March 8, 2019.

“We are pleased RTI’s shareholders have given their strong support for our acquisition of Paradigm Spine,” said Camille Farhat, President and CEO, RTI Surgical. “With shareholder approval secured, we look forward to closing the acquisition and strengthening our spine portfolio with the addition of the coflex® Interlaminar Stabilization® device. Coflex is a differentiated and minimally invasive motion preserving stabilization implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS) in conjunction with decompression. This milestone represents another advance in RTI’s strategic transformation to reduce complexity, drive operational excellence and accelerate growth.”

About RTI Surgical, Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic and trauma procedures and are distributed in nearly 50 countries. RTI has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com. Connect with us on LinkedIn and Twitter.